Table 2 Distribution of the clinical and radiomic variables
Factor | Median value/n | p value | |
|---|---|---|---|
Radio-sensitive group | Radio-resistant group | ||
Age (years) | 70 | 71 | 0.814 |
PSA serum concentration (ng/ml) | 7.5 | 5.63 | 0.015 |
GTV-PET (ml) | 1.95 | 1.6 | 0.593 |
GTV-MRI (ml) | 0.8 | 0.8 | 0.816 |
SUV-max | 16.65 | 6.97 | 0.037 |
SUV-mean | 7.99 | 4.44 | 0.028 |
ADC-min | 1589 | 1766 | 0.437 |
ADC-mean | 895 | 1022 | 0.049 |
ADT (n) | 4 | 4 | > 0.999 |
GS | > 0.999 | ||
6 | 1 | 1 | |
7a | 4 | 4 | |
7b | 2 | 2 | |
8 | 2 | 2 | |
9 | 0 | 0 | |
cT stage | PSMA PET/MRI | PSMA PET/MRI | |
|---|---|---|---|
T2a | 0/1 | 2/1 | 0.176 (PSMA PET) |
T2b | 0/0 | 0/0 | |
T2c | 2/0 | 2/1 | |
T3a | 1/5 | 2/3 | 0.705 (MRI) |
T3b | 4/1 | 0/0 | |
T4 | 0/0 | 0/0 |